<DOC>
	<DOCNO>NCT01769807</DOCNO>
	<brief_summary>Reduced plasma nitrate ( NOx ) level increase urinary norepinephrine ( U-NE ) level describe severe obstructive sleep apnea ( OSA ) , revert continuous positive airway pressure ( CPAP ) . The investigator want know effect CPAP biomarkers mild-moderate OSA .</brief_summary>
	<brief_title>Efficacy Study CPAP Nitrate Norepinephrine Levels Severe Mild-moderate Sleep Apnea ( SABIO )</brief_title>
	<detailed_description>The investigator aim compare NOx U-NE level blood pressure ( BP ) male patient mild-moderate severe OSA determine impact 1 month CPAP therapy parameter . The investigator undertake prospective study 67 consecutive OSA patient ( 36 mild-moderate , 31 severe ) . Measurements plasma NOx 11 pm , 4 7 , 24-h U-NE ambulatory BP obtain baseline 1 month CPAP .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<criteria>Diagnosis obstructive sleep apnea current smoker respiratory disease cardiac disease ( except arterial hypertension ) renal disorder hepatic disorder psychiatric disorder diabetes mellitus dyslipidemia rhinitis sinusitis acute illness daytime hypoxemia hypercapnia therapy oral nitrate therapy angiotensinconverting enzyme inhibitor therapy betablockers therapy statin therapy nonsteroidal antiinflammatory drug presence central respiratory event previous CPAP therapy previous uvulopalatopharyngoplasty</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Sleep apnea</keyword>
	<keyword>CPAP treatment</keyword>
	<keyword>Plasma nitrate</keyword>
	<keyword>Urinary norepinephrine</keyword>
	<keyword>Blood pressure</keyword>
</DOC>